| Wienhold, Daniel (Deutsche Bank 201701 Head of Expert Team Life Sciences joined 200808 before IDT Biologika) |
n. a. |
Deutsche Bank (Group) |
Germany |
| Wieschaus, Eric (European Molecular Biology Laboratory, 201503) |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Wiese, Hanns-Peter (Global Life Science Ventures 201105 Managing Director) |
Managing Director |
Global Life Science Ventures (Group) |
Germany |
| Wiesel, Philippe (AgomAb Therapeutics 202103– CMO before Genkyotex + Serono in US + CH) |
Chief Medical Officer (CMO) |
Calliditas Therapeutics (Group) |
Switzerland |
| Wieser, Jochen (Optimare 201003 Dept of Science) |
Researcher (industry) |
Aerodata (Group) |
Germany |
| Wiesmüller, Karl-Heinz (EMC microcollections CEO) |
Chief Executive Officer (CEO) |
EMC microcollections GmbH |
Germany |
| Wiessner, Christoph (Asceneuron 201509 COO) |
Chief Operating Officer (COO) |
Asceneuron S.A. |
Switzerland |
| Wiest, Christian (iThera Medical 201110 Managing Director) |
Managing Director |
iThera Medical GmbH |
Germany |
| Wiest, Joachim (Cellasys GmbH 201201 Managing Director) |
Managing Director |
Cellasys GmbH |
Germany |
| Wiest, Kajo (Humedics 202302 Manager Finance + Controlling) |
Chief Financial Officer (CFO) |
Humedics GmbH |
Germany |
| Wiestler, Otmar D. (Helmholtz 201211 Head of DKFZ) |
President/Director/Head Business Group/Unit/Division |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Wiestler, Otmar D. (Helmholtz 202306 President of Helmholtz Association) |
President/Director/Head of Research Organisation/Unit |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Wigerinck, Piet (Galapagos 201304 CSO before SVP Developm before Tibotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Galapagos (Group) |
Belgium |
| Wiggenhorn, Michael (Coriolis Pharma 2008– Managing Director + Co-Founder) |
Managing Director |
Coriolis Pharma (Group) |
Germany |
| Wiggenhorn, Thomas (Coriolis Pharma 2008– Managing Director + Co-Founder) |
Managing Director |
Coriolis Pharma (Group) |
Germany |
| Wiggins, Dale (Philips 201810 Business Leader HealthSuite Digital Platform) |
Product Manager (personnel) |
Philips (Group) |
Netherlands |
| Wijn, Annemieke |
n. a. |
Kraft Foods (Group) |
Germany |
| Wiklund, Jesper P. (Index Pharmaceuticals 201109– CEO before Sobi before Affectis + Evotec OAI + DeveloGen + Elan) |
Chief Executive Officer (CEO) |
InDex Pharmaceuticals (Group) |
Sweden |
| Wilbur, Christina (Roche 201603– Head of Global Human Resources + Member of Corp Executive Committe joined Roche 2002) |
Human Resources Manager |
Roche (Group) |
Switzerland |
| Wilcke, Ulf |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Wilckens, Thomas (InnVentis 201409) |
n. a. |
InnVentis Ltd. |
Germany |
| Wild, Alexander (Innerspace 202111 Managing Director) |
Managing Director |
Innerspace GmbH |
Austria |
| Wild, Anthony H. (Bows Pharmaceuticals AG 200610– General Partner before MedPointe Pharma CEO before Warner-Lambert) |
General Partner (venture partner) |
Bows Pharmaceuticals AG |
Switzerland |
| Wild, Hanno (Bayer 201312 SVP + Head Candidate Generation + Exploration at Bayer HealthCare Global Drug Discovery) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Wild, Hans-Peter (Wild Group 201509 Owner + Chairman) |
Board member |
Wild Group (Group) |
|
| Wildanger, Oliver (Genetics Company 200512) |
n. a. |
Genetics Company Inc., The |
Switzerland |
| Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Compass Pathways (Group) |
United Kingdom (GB) |
| Wilde, Matthias (Sachsen (govt) 202207 Saxony Trade + Invest Life Sciences) |
Trade Promotion Manager / Regional Business Development Manager |
Saxony (govt region) |
Germany |
| Wilden, Peter (PolyPeptide 202304 Executive Chair) |
Board member |
PolyPeptide (Group) |
Switzerland |
| Wilhelm, Andreas (Tecan 2012 promoted General Counsel + Management Board Member before Head Legal Affairs) |
General Counsel / Chief Legal Officer (CLO) |
Tecan (Group) |
Switzerland |
| Wilhelm, Olaf Georg (Therawis 201405– Managing Director before Wilex 2001–201403 CEO) |
Chief Executive Officer (CEO) |
Therawis (Group) |
Germany |
| Wilhelmsson, Claes |
Investment Manager |
Investor AB (Wallenberg) (Group) |
Sweden |
| Wilkens, Jochen (Chemie Nord 201010 Managing Director) |
Managing Director |
Chemie Nord – Arbeitgeberverband für die Chemische Industrie in Norddeutschland e. V. |
Germany |
| Wilkinson, Malcolm (Kirkstall 201802 CEO) |
Chief Executive Officer (CEO) |
Kirkstall (GB) |
United Kingdom (GB) |
| Wilkinson, Michael (MiniFAB 201906 Executive Director + acting CEO) |
Chief Executive Officer (CEO) |
Schott (Group) |
Australia |
| Wilks, Chris (Sonic Healthcare 201701 CFO + Finance Director) |
Chief Financial Officer (CFO) |
Sonic Healthcare (Group) |
Australia |
| Willbold, Dieter (Univ Düsseldorf + FZ Jülich 202102 Prof + Co-Founder of Priavoid) |
Professor |
University of Düsseldorf (Heinrich-Heine-Universität) |
Germany |
| Willems, Frank (NonWoTecc Medical 201107 Managing Director) |
Managing Director |
NonWoTecc Medical GmbH |
Germany |
| Williams, Antony (RSC 200905– VP Strategic Development before ChemZoo 200804 President) |
n. a. |
Royal Society of Chemistry, The (RSC) |
United Kingdom (GB) |
| Williams, David (Nanna Therapeutics 202004 CEO before Discuva) |
Chief Executive Officer (CEO) |
Astellas (Group) |
United Kingdom (GB) |
| Williams, James (Siemens 201304 CEO of Siemens Molecular Imaging business unit) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| WIlliams, Jeff (Clinipace 201504 CEO) |
Chief Executive Officer (CEO) |
Clinipace (Group) |
United States (USA) |
| Williams, Jeff (NeuMoDx 201809 CEO) |
Chief Executive Officer (CEO) |
NeuMoDx Moleuclar Inc. |
United States (USA) |
| Williams, Jon (Aquapharm Biodiscovery 201207 VP Commercial) |
Chief Commercial Officer (CCO) |
Aquapharm Biodiscovery Ltd. |
United Kingdom (GB) |
| Williams, Lewis T. (Five Prime –200910– Founder + Executive Chairman) |
Company Founder |
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) (FivePrime) |
United States (USA) |
| Williamson, Anna (Roche 202106 Executive Director Business Development + Head UK BusDev at Roche/Genentech) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
| Willing, Lydia (BioEcho 202209– General Manager of BioEcho Life Sciences Inc.) |
General Manager (management) |
BioEcho (Group) |
United States (USA) |
| Willinger, Peter (Apogenix 201506– CFO before Sygnis Pharma + Lion Bioscience) |
Chief Financial Officer (CFO) |
Apogenix AG |
Germany |
| Willinger, Thomas R. (ZFHN Zukunftsfonds Heilbronn 201105 Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Willinsky, Brian (PerkinElmer 201403) |
Public Relations Manager / Investor Relations Manager |
PerkinElmer (Group) |
United States (USA) |
| Willkommen, Hannelore (NewLab BioQuality 200504– VP Regulatory Affairs before Clearant before Paul Ehrlich Institute) |
Regulatory Affairs Manager |
Charles River (Group) |
Germany |
| Willmitzer, Lothar (Max Planck 201006 Managing Director MPI for Molecular Plant Physiology) |
President/Director/Head of Research Organisation/Unit |
Max Planck Society for the Advancement of Science |
Germany |
| Willms, Andrea (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Wills, Robert J. (Rob) (at JnJ 25 years before Roche) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Wilmanns, Max (GSK Stockmann 201704 Lawyer + Partner at Hamburg Office) |
Attorney / Lawyer |
|
|
| Wilson, Charles (Chuck) (Novartis 201204 Global Head Strategic Alliances before Archemix + Univ California Santa Cruz) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Wilson, Dow R. (Varian Medical Systems 201412 CEO) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
United States (USA) |
| Wilson, Julia (Achilles Therapeutics 202011 Head of Communications + JW Communications 201209– before Vectura Group) |
Public Relations Manager / Investor Relations Manager |
JW Communications Ltd. |
United Kingdom (GB) |
| Wilson, O’Patrick (O Public Relations 202302 Managing Partner + Owner before Syngenta + Ciba Specialty Chemicals) |
Managing Partner |
O Public Relations GmbH |
Germany |
| Wilton, Jane (Philogen SpA 201510 Director Business Development) |
Business Development Manager / Strategy Manager |
Philogen (Group) |
Italy |
| Wimmer, Bartl (Synlab 201408 Managing Director) |
Managing Director |
Synlab (Group) |
Germany |
| Wimmer, Bernhard (BioM AG 200603) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Wimmer, Sylvia (Heidelberg Pharma 202203 Corporate Communciations formerly Wilex 201403 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Heidelberg Pharma (Group) |
Germany |
| Windeler, Jürgen (IQWiG 201312 Head of Institute) |
President/Director/Head Business Group/Unit/Division |
IQWiG (German Centre for Quality and Efficiency in Health Services) |
Germany |
| Windels, Hilde (Biocartis 201107– CFO + managing director Biocartis NV before Devgen 1999–2008 CFO) |
Chief Financial Officer (CFO) |
Biocartis (Group) |
Switzerland |
| Windhab, Norbert |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
| Windham-Bannister, Susan (Massachusetts Life Sciences Center 201310 CEO) |
Chief Executive Officer (CEO) |
Massachusetts (govt region) |
United States (USA) |
| Windisch, Jörg (Affimed 201601– COO before 20y at Sandoz Biopharmaceuticals (Novartis)) |
Chief Operating Officer (COO) |
Affimed (Group) |
Germany |
| Windisch, Manfred (JSW-Research 200512 CEO) |
Chief Executive Officer (CEO) |
JSW-Research (Group) |
Austria |
| Windt, Jana (Minapharm 202403 Head of Marketing + Communications) |
Sales Manager / Marketing Manager |
Minapharm (Group) |
Germany |
| Wingender, Edgar (geneXplain 201004– Managing Director + Univ Medical Center Göttingen 201601 Institute of Bioinform) |
Managing Director |
geneXplain GmbH |
Germany |
| Winkler, Frank (Univ Heidelberg + DKFZ 201909 Professor + Co-Founder of Divide & Conquer) |
Professor |
University of Heidelberg (Ruperto Carola) |
|
| Winkler, Karl (Anagnostics 201210– Sales Manager direct sales to hospitals in DE + AT + CH before Heinen & Löwenstein) |
Sales Manager / Marketing Manager |
Cube Dx GmbH |
Austria |
| Winkler, Katrin (Qiagen 200810 Associate Director Global Organisational Professional Development) |
training (employee) |
Qiagen (Group) |
Germany |
| Winkler, Ron (High-Tech Gründerfonds 201207 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Winnacker, Ernst-Ludwig |
n. a. |
DFG (Deutsche Forschungsgemeinschaft) |
Germany |
| Winnemöller, Dirk (Leukocare 202111– VP Commercial before Miltenyi Biomedicine GmbH) |
Chief Commercial Officer (CCO) |
Leukocare (Group) |
Germany |
| Winnen, Pascal (Hemex AG 201901 CEO) |
Chief Executive Officer (CEO) |
Hemex AG |
|
| Winroth, Jörgen (Swedish Orphan Biovitrum 201512 VP + Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Winter, Babette |
n. a. |
Tecmedic GmbH |
Germany |
| Winter, Gerwin (BeiGene 202111 Head of Commercial Europe) |
Sales Manager / Marketing Manager |
BeiGene (Group) |
Switzerland |
| Winter, Jörn (Nebula Biocides 202111 Managing Director + Co-Founder) |
Managing Director |
Nebula Biocides GmbH |
Germany |
| Winter, Martin (Cetics 201103c BusDev + Co-founder + Lab Automation Network before Accelab GmbH) |
Business Development Manager / Strategy Manager |
Cetics Healthcare Technologies, Dr. Martin Winter |
Germany |
| Winter, Nina (miRdetect GmbH 2016– Managing Director + Company Founder) |
Managing Director |
miRdetect GmbH |
Germany |
| Winter, Peter (GenXPro GmbH 201402 Managing Director) |
Managing Director |
GenXPro GmbH |
Germany |
| Winter, Thomas (Genius Search 2018– Managing Director + Founder before Mediatum since 2009) |
Managing Director |
Genius Search (Group) |
Germany |
| Winterberg, Britta (Formo 202202 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Formo (Group) |
Germany |
| Winterhalter, Christoph (Rentschler –201411–201802 Business Development Manager LEFT 2/18) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
Germany |
| Winterhalter, Mathias (Jacobs Univ Bremen 2009 Professor School of Engineering and Science) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
| Winzer, Ludwig (Ocimum Germany GmbH 200606– Managing Director) |
Managing Director |
Ficus Enterprises (Group) |
Germany |
| Winzer, Marco (High-Tech Gründerfonds 200701 Investment Manager) |
n. a. |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Winzker-Demes, Daniela (Scientific Industries 202104– VP of Sales EMEA + Asia at SBI before Sartorius) |
Sales Manager / Marketing Manager |
Scientific Industries (Group) |
Germany |
| Wirges, Anthea (CARTemis Therapeutics 202308– Managing Director + Co-Founder before Max Delbrück Center) |
Managing Director |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Wiring, Roland (CMS 201508 Attorney at CMS Hasche Sigle Hamburg advising life sciences + med tech firms) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Wirsching, Christian (Cinference 202012– Managing Director) |
Managing Director |
Cinference UG (haftungsbeschränkt) |
Germany |
| Wirsching, Sandra (Biocom AG 2005– Editor) |
Editor / Publisher |
Biocom (Group) |
Germany |
| Wirth, Jean-Charles (Merck (DE) 201708 Head of Applied Solutions business unit, Life Science) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Wirth, Thomas (LSCN Ltd 201710 Managing Director) |
Managing Director |
LSCN Ltd. (Life Science Consulting Network) (DE) |
Germany |
| Wirtz, Ralph Markus (Stratifyer Molecular Pathology GmbH 201311 Managing Director) |
Managing Director |
Stratifyer Molecular Pathology GmbH |
Germany |
| Wirz, Konrad P. (Speedel 200508 CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 86 87 88 ... 89 90 91 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
